Adaptix provides technology to allow low-cost low-dose 3D imaging at the bedside or GP's clinic. The Company is adding low-dose 3D capability – digital tomosynthesis – to planar X-ray while making it more affordable and truly portable so radiology can more easily travel to the patient. This transformation will enhance patient’s access to the world’s most important imaging technologies and likely increases the diagnostic accuracy for many high incidence conditions such as cardiovascular and pulmonary diseases, lung cancer and osteoporosis.

Oxfordshire, GB
Size (employees)
25 (est)-3%
Adaptix is headquartered in Oxfordshire, GB
Report incorrect company information

Key People/Management at Adaptix

Mark Evans

Mark Evans

Chief Executive Officer
Kristin Schmiedehausen

Kristin Schmiedehausen

Chief Medical Officer
Gil Travish

Gil Travish

Chief Scientific Officer
Chris Smith

Chris Smith

Chief Financial Officer & Company Secretary

Adaptix Office Locations

Adaptix has an office in Begbroke and Oxfordshire
Oxfordshire, GB (HQ)
Woodstock Rd
Begbroke, GB
Begbroke Ln
Show all (2)
Report incorrect company information

Adaptix Financials and Metrics

Summary Metrics

Time since last funding

2 years ago


Adaptix Financials

Adaptix's revenue was reported to be £125 k in FY, 2017

Revenue (FY, 2017)

125 k

Gross profit (FY, 2017)

(208.3 k)

Gross profit margin (FY, 2017), %


Net income (FY, 2017)

(904.7 k)

EBITDA (FY, 2017)

(1.2 m)

EBIT (FY, 2017)

(1.2 m)

Cash (6-Mar-2018)

44.5 k
GBPFY, 2010FY, 2014FY, 2015FY, 2016FY, 2017


132.8 k125 k

Cost of goods sold

8 k464.1 k464.6 k333.3 k

Gross profit

(331.7 k)(208.3 k)

Gross profit Margin, %

GBPFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


37.1 k12.4 k32.6 k3.4 k1.6 k352.4 k129.9 k44.5 k

Accounts Receivable

123 k20 k

Current Assets

37.1 k12.4 k32.6 k6.2 k1.6 k406.5 k384.8 k392.6 k


8.4 k15.2 k33.4 k
GBPFY, 2010FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(11 k)(59.1 k)(536.1 k)(507.1 k)(904.7 k)

Income Taxes Paid

40.3 k60.5 k
GBPY, 2017


9.3 k

Financial Leverage

2.9 x
Show all financial metrics
Report incorrect company information